Needham Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $6

Futu NewsNov 5 19:36 · Ratings

Bullish Taysha Gene Therapies Insider Buying Worth US$3.16m Yet To Pay Off

Simply Wall StNov 1 22:00

Cantor Fitzgerald Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $7

Futu NewsOct 31 19:34 · Ratings

Baird Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $7

Futu NewsOct 24 23:31 · Ratings

Optimism for Taysha Gene Therapies: Promising Preclinical Data and Upcoming Catalysts Drive Buy Rating

TipRanksOct 24 22:48 · Ratings

CCORF Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating, Maintains Target Price $6

Futu NewsOct 23 20:31 · Ratings